A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
We are a leading provider of home health and hospice services in the United States. We strive to provide our patients with superior clinical care, where our patients prefer it: in their homes. For over 25 years, we have provided care in the low-cost home setting while achieving high-quality clinical outcomes and demonstrating a consistent ability to innovate during varying economic and regulatory climates. As of December 31, 2025, we operated 249 home health and 117 hospice locations across 34 states. We operate our business in two segments, Home Health and Hospice. Each provides a comprehensive range of high‑quality, Medicare-certified services. •Our Home Health segment provides skilled home health services, including nursing care, physical, occupational and speech therapy, medical social work, and home health aide services. For the year ended December 31, 2025, our Home Health segment had an average daily census of 41,786 and generated $813.8 million in Net service revenue, or 76.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 1.1B | 1.1B | 1.0B | 1.0B | 1.1B | 1.1B |
| Net Income | -4.6M | -4.6M | -156M | -81M | -40M | 111M |
| EPS | $-0.09 | $-0.09 | $-3.11 | $-1.61 | $-0.81 | $2.24 |
| Free Cash Flow | 66M | 66M | 47M | 45M | 73M | 119M |
| ROIC | 1.3% | 1.0% | -15.4% | -6.4% | -0.8% | 7.6% |
| Gross Margin | 49.0% | 49.0% | 48.7% | 48.8% | 50.9% | 53.6% |
| Debt/Equity | 0.98 | 0.98 | 1.13 | 0.91 | 0.84 | 0.04 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 16M | 16M | -115M | -48M | -11M | 143M |
| Operating Margin | 1.5% | 1.5% | -11.1% | -4.5% | -1.1% | 12.9% |
| ROE | -0.9% | -0.9% | -29.8% | -11.4% | -3.7% | 7.8% |
| Shares Outstanding | 51M | 51M | 50M | 50M | 50M | 50M |
| Metric | 2020 | 2021 | 2022 | 2023 | |||
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 1.1B | 1.1B | 1.1B | 1.0B | 1.0B | 1.1B | 1.1B |
| Gross Margin | 50.1% | 53.6% | 50.9% | 48.8% | 48.7% | 49.0% | 49.0% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 398M | 413M | 415M | 442M | 426M | 434M | 434M |
| EBIT | 103M | 143M | -11M | -48M | -115M | 16M | 16M |
| Op. Margin | 9.5% | 12.9% | -1.1% | -4.5% | -11.1% | 1.5% | 1.5% |
| Net Income | 75M | 111M | -40M | -81M | -156M | -4.6M | -4.6M |
| Net Margin | 7.0% | 10.0% | -3.8% | -7.7% | -15.1% | -0.4% | -0.4% |
| Non-Recurring | 0 | 0 | 109M | 86M | 162M | 45M | 45M |
| Returns on Capital | |||||||
| ROIC | 7.9% | 7.6% | -0.8% | -6.4% | -15.4% | 1.0% | 1.3% |
| ROE | 7.3% | 7.8% | -3.7% | -11.4% | -29.8% | -0.9% | -0.9% |
| ROA | N/A | 13.0% | -2.5% | -5.4% | -12.7% | -0.4% | -0.4% |
| Cash Flow | |||||||
| Op. Cash Flow | 25M | 123M | 80M | 48M | 51M | 71M | 71M |
| Free Cash Flow | 22M | 119M | 73M | 45M | 47M | 66M | 66M |
| Owner Earnings | -19M | 83M | 38M | 8.6M | 8.0M | 32M | 32M |
| CapEx | 3.2M | 4.3M | 7.1M | 3.5M | 3.8M | 4.9M | 4.9M |
| Maint. CapEx | 40M | 37M | 33M | 31M | 32M | 23M | 23M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 40M | 37M | 33M | 31M | 32M | 23M | 23M |
| CapEx/OCF | N/A | N/A | 8.9% | 7.2% | 7.4% | N/A | 6.9% |
| Capital Allocation | |||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 3.9M | 3.6M | 9.2M | 8.9M | 12M | 17M | 17M |
| Debt Repayment | 1.1M | 0 | 10M | 20M | 20M | 20M | 20M |
| Balance Sheet | |||||||
| Net Debt | -39M | 52M | 602M | 583M | 536M | 435M | 479M |
| Cash & Equiv. | 40M | 5.4M | 23M | 27M | 28M | 44M | 44M |
| Long-Term Debt | 1.1M | 3.5M | 560M | 530M | 493M | 426M | 426M |
| Debt/Equity | 0.00 | 0.04 | 0.84 | 0.91 | 1.13 | 0.98 | 0.98 |
| Interest Coverage | 256.8 | 714.5 | -0.8 | -1.1 | -2.7 | 0.5 | 0.5 |
| Equity | 1.4B | 1.5B | 742M | 670M | 524M | 534M | 534M |
| Total Assets | -8.7M | 1.7B | 1.5B | 1.4B | 1.2B | 1.2B | 1.2B |
| Total Liabilities | 13M | 237M | 752M | 732M | 672M | 603M | 603M |
| Intangibles | N/A | 259M | 103M | 80M | 58M | 39M | 39M |
| Retained Earnings | N/A | 375M | 335M | 255M | 98M | 94M | 94M |
| Working Capital | N/A | 42M | 79M | 72M | 67M | 79M | 79M |
| Current Assets | N/A | 179M | 212M | 210M | 193M | 206M | 206M |
| Current Liabilities | N/A | 137M | 133M | 138M | 126M | 126M | 126M |
| Per Share Data | |||||||
| EPS | 1.51 | 2.24 | -0.81 | -1.61 | -3.11 | -0.09 | -0.09 |
| Owner EPS | -0.38 | 1.67 | 0.76 | 0.17 | 0.16 | 0.62 | 0.62 |
| Book Value | 27.98 | 29.64 | 14.87 | 13.39 | 10.42 | 10.45 | 10.45 |
| Cash Flow/Share | 0.50 | 2.49 | 1.61 | 0.97 | 1.02 | 1.38 | 0.35 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 49.7M | 49.6M | 49.9M | 50.0M | 50.2M | 51.1M | 51.1M |
| Valuation | |||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | -154.9 |
| P/FCF | N/A | N/A | 8.9 | 11.8 | 8.1 | N/A | 10.8 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | 74.0 |
| Price/Book | N/A | N/A | 0.9 | 0.8 | 0.7 | N/A | 1.3 |
| Price/Sales | N/A | N/A | 0.7 | 0.6 | 0.4 | N/A | 0.7 |
| FCF Yield | N/A | N/A | 11.3% | 8.5% | 12.3% | N/A | 9.2% |
| Market Cap | 0 | N/A | 648M | 530M | 386M | 0 | 712M |
| Avg. Price | 0.00 | N/A | 15.25 | 12.23 | 8.97 | 0.00 | 13.94 |
| Year-End Price | 0.00 | N/A | 13.00 | 10.61 | 7.68 | 0.00 | 13.94 |
Enhabit, Inc. passes 2 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 12.2x vs a median of 8.9x. The company's 5-year average gross margin is 50.2%. At current prices, the estimated annualized return to fair value is -16.2%.
Enhabit, Inc. (EHAB) has a 5-year average return on invested capital (ROIC) of -2.8%. This is below average and may indicate limited pricing power.
Enhabit, Inc. (EHAB) has a market capitalization of $712M. It is classified as a small-cap stock.
Enhabit, Inc. (EHAB) does not currently pay a regular dividend.
Enhabit, Inc. (EHAB) operates in the Services-Home Health Care Services industry, within the Healthcare sector.
Enhabit, Inc. (EHAB) reported annual revenue of $1.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
Enhabit, Inc. (EHAB) has a net profit margin of -0.4%. The company is currently unprofitable.
Enhabit, Inc. (EHAB) generated $66 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Enhabit, Inc. (EHAB) has a debt-to-equity ratio of 0.98. This indicates moderate leverage.
Enhabit, Inc. (EHAB) reported earnings per share (EPS) of $-0.09 in its most recent fiscal year.
Enhabit, Inc. (EHAB) has a return on equity (ROE) of -0.9%. A negative ROE may indicate losses or negative equity.
Enhabit, Inc. (EHAB) has a 5-year average gross margin of 50.2%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 6 years of financial data for Enhabit, Inc. (EHAB), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Enhabit, Inc. (EHAB) has a book value per share of $10.45, based on its most recent annual SEC filing.